Literature DB >> 29969762

In Vitro Study of Endotoxin Adsorption by a Polymyxin B-Immobilized Fiber Column.

Chizuru Yamashita1, Kazuhiro Moriyama2, Daisuke Hasegawa1, Yu Kato1, Toshikazu Sakai1, Takahiro Kawaji1, Yasuyo Shimomura1, Yasuyoshi Kurimoto1, Mariko Nagata1, Osamu Nishida1.   

Abstract

BACKGROUND: Polymyxin B-immobilized fiber (PMX-F) columns are used as therapeutic interventions for septic shock. The clinical efficacy has been reported for 2-h applications, but their ability to adsorb endotoxin over longer treatments has not been fully elucidated. We hypothesized that PMX-F columns are capable of endotoxin removal for more than 2 h.
METHOD: We designed closed circuits incorporating either a PMX-F column with an 8.5-mL priming volume (PMX-01R) or a sham-control column, and used inactivated fetal bovine serum as the circulating perfusate. Endotoxin was continuously injected at a fixed rate for 24 h, and perfusate endotoxin concentrations were measured at fixed time points. PMX-01R endotoxin adsorption was calculated from the difference in the endotoxin concentrations.
RESULTS: PMX-01R endotoxin adsorption increased continuously in a virtually linear manner.
CONCLUSIONS: The PMX-01R column showed sustained endotoxin adsorption for at least 24 h. This indicated that PMX-F columns would be capable of clinical endotoxin removal for 24 h. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  24-h hemoperfusion; Adsorption saturation; Continuous endotoxin injection; Endotoxin adsorption; Polymyxin B-immobilized fiber

Mesh:

Substances:

Year:  2018        PMID: 29969762      PMCID: PMC6214612          DOI: 10.1159/000489920

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

Review 1.  Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.

Authors:  H Shoji; T Tani; K Hanasawa; M Kodama
Journal:  Ther Apher       Date:  1998-02

2.  Polymyxin B hemoperfusion in sepsis: growing body of evidence and occasional conflicting results.

Authors:  Massimo Antonelli; Claudio Ronco
Journal:  Blood Purif       Date:  2015       Impact factor: 2.614

3.  Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.

Authors:  Chieko Mitaka; Naoto Fujiwara; Mamoru Yamamoto; Takahiro Toyofuku; Go Haraguchi; Makoto Tomita
Journal:  J Crit Care       Date:  2014-04-04       Impact factor: 3.425

4.  Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.

Authors:  Chizuru Yamashita; Yoshitaka Hara; Naohide Kuriyama; Tomoyuki Nakamura; Osamu Nishida
Journal:  Ther Apher Dial       Date:  2015-08       Impact factor: 1.762

5.  Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.

Authors:  Didier M Payen; Joelle Guilhot; Yoann Launey; Anne Claire Lukaszewicz; Mahmoud Kaaki; Benoit Veber; Julien Pottecher; Olivier Joannes-Boyau; Laurent Martin-Lefevre; Matthieu Jabaudon; Olivier Mimoz; Rémi Coudroy; Martine Ferrandière; Eric Kipnis; Carlos Vela; Stéphanie Chevallier; Jihad Mallat; René Robert
Journal:  Intensive Care Med       Date:  2015-04-11       Impact factor: 17.440

  5 in total
  1 in total

1.  Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion for Micro-Preemie Infants with Septic Shock. Is Extended Duration Better than Early Start? Comment to the Letter to the Editor of Nishizaki and Colleagues.

Authors:  Chieko Mitaka; Toshiaki Iba; Claudio Ronco
Journal:  Blood Purif       Date:  2021-09-16       Impact factor: 3.348

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.